The UpPriority tool was developed to guide the prioritization of clinical guideline questions for updating
Por:
Sanabria, AJ, Pardo-Hernandez, H, Ballesteros, M, Canelo-Aybar, C, McFarlane, E, de Guzman, EN, Penman, K, Posso, M, Figuls, MRI, Selva, A, Vernooij, RWM, Alonso-Coello, P, Garcia, LM, G-I-N Updating Guidelines Working
Publicada:
1 oct 2020
Ahead of Print:
19 jun 2020
Resumen:
Objective: The objective of the study is to develop a pragmatic tool to prioritize clinical guideline (CG) questions for updating, the UpPriority tool.
Study Design and Setting: The development of this tool consisted of the following: (1) establishment of the working group, (2) generation of the initial version, (3) optimization of the tool (including an initial feasibility test, semistructured interviews, Delphi consensus survey, second feasibility test, external review, and pilot test), and (4) approval of the final version.
Results: A total of 87 participants including methodologists, clinicians, and other relevant stakeholders contributed to the development of the UpPriority tool. The tool consists of six items: (1) impact of outdated recommendations on safety, (2) availability of new relevant evidence, (3) context relevance of the clinical question, (4) methodological applicability of the clinical question, (5) user's interest, and (6) impact on access to health care. The UpPriority tool includes detailed guidance for using the tool and rating each item (using a 7-point Likert scale), for calculating and ranking the questions, and for summarizing results.
Conclusion: The UpPriority tool could be useful for standardizing prioritization processes when updating CGs and for fostering more efficient use of resources in the CG field. (C) 2020 Elsevier Inc. All rights reserved.
Filiaciones:
Sanabria, AJ:
Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain
Natl Inst Hlth & Care Excellence, Manchester, Lancs, England
GIN Updating Guidelines Working Grp, Edinburgh, Midlothian, Scotland
Pardo-Hernandez, H:
Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain
GIN Updating Guidelines Working Grp, Edinburgh, Midlothian, Scotland
CIBER Epidemiol & Publ Hlth CIBERESP, Barcelona, Spain
Ballesteros, M:
Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain
Canelo-Aybar, C:
Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain
CIBER Epidemiol & Publ Hlth CIBERESP, Barcelona, Spain
McFarlane, E:
Natl Inst Hlth & Care Excellence, Manchester, Lancs, England
GIN Updating Guidelines Working Grp, Edinburgh, Midlothian, Scotland
de Guzman, EN:
Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain
Penman, K:
Natl Inst Hlth & Care Excellence, Manchester, Lancs, England
GIN Updating Guidelines Working Grp, Edinburgh, Midlothian, Scotland
Posso, M:
Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain
Figuls, MRI:
Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain
Selva, A:
GIN Updating Guidelines Working Grp, Edinburgh, Midlothian, Scotland
Corp Sanitaria Parc Tauli, Clin Epidemiol & Canc Screening, Barcelona, Spain
Vernooij, RWM:
Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain
GIN Updating Guidelines Working Grp, Edinburgh, Midlothian, Scotland
Alonso-Coello, P:
Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain
GIN Updating Guidelines Working Grp, Edinburgh, Midlothian, Scotland
CIBER Epidemiol & Publ Hlth CIBERESP, Barcelona, Spain
Garcia, LM:
Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain
GIN Updating Guidelines Working Grp, Edinburgh, Midlothian, Scotland
CIBER Epidemiol & Publ Hlth CIBERESP, Barcelona, Spain
|